Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma

Addition of induction chemotherapy (IC) to concurrent chemoradiotherapy (CC) is an encouraging first-line treatment strategy for patients with locoregionally advanced nasopharyngeal carcinoma (NPC). We evaluated the clinical efficacy and toxicity of addition of gemcitabine plus cisplatin (GP) IC to...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Fangzheng, Wang, Quanquan, Sun, Chuner, Jiang, Lei, Wang, Fengqin, Yan, Zhimin, Ye, Tongxin, Liu, Min, Xu, Peng, Wu, Haitao, Jiang, Aizawa, Rihito, Sakamoto, Masoto, Yuezhen, Wang, Zhenfu, Fu
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5722524/
https://ncbi.nlm.nih.gov/pubmed/29228572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18245
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items